Sign in
8-K/A

Current Report

Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-19-031925

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading tv524051_8ka.htm…